Don't Be Misled by RCTs in LLM Biosecurity Risk Assessments
paulnovosad · x · 2026-07-14
The author argues that dismissing concerns about "LLMs significantly helping novices with molecular biology tasks, thereby elevating 2028 biosecurity risks" based on a single randomized controlled trial (RCT) is a flawed conclusion. Their reasoning is: - **Those who pose actual biosecurity risks aren't novices**, so results from "novice experiments" may not represent the real threat actors. - **People often don't use LLMs optimally at first**, but their proficiency improves with practice; short-term RCTs tend to underestimate long-term effects. - In a small team setting, proficient users can easily pass these methods on to other members, meaning a RCT's independent and identically distributed estimates don't necessarily extrapolate to collaborative team environments. The core takeaway: one cannot simply map short-term experimental results directly onto real-world threat assessments.
More from AGI Musings
- Jamie Dimon says bureaucracy, not AI, is the real system crushing intelligence — r0ck3t23 · 2026-07-21
- OpenAI and Anthropic’s internal models are said to be far stronger than today’s public systems — scaling01 · 2026-07-21
- Superintelligence and robot abundance will force a new social contract — Dr_Singularity · 2026-07-21
- The Guardian examines how AI companionship is turning intimacy into an economy — nordicinst · 2026-07-21
- A frustrated user says modern AI keeps hallucinating on real-world repair tasks — doochenutz · 2026-07-21
- A repost argues that AI will make today’s hard tasks trivial within months — OwariDa · 2026-07-21